The impact of obesity on health care costs among persons with schizophrenia
about
Quetiapine versus other atypical antipsychotics for schizophreniaAntipsychotic drug treatment for elderly people with late-onset schizophreniaZiprasidone versus other atypical antipsychotics for schizophreniaReview of the evidence: prevalence of medical conditions in the United States population with serious mental illnessThe use of psychiatric drugs and worsening body mass index among inpatients with schizophreniaDietary patterns are associated with obesity in Japanese patients with schizophrenia.Direct medical cost of overweight and obesity in the USA: a quantitative systematic review.Association of psychiatric illness and all-cause mortality in the National Department of Veterans Affairs Health Care SystemBody mass index and quality of life among outpatients with schizophrenia in JapanExpanding Cessation Pharmacotherapy Via Videoconference Educational Outreach to Prescribers.Body composition in patients with schizophrenia: Comparison with healthy controls.Attitudes toward metabolic adverse events among patients with schizophrenia in Japan.A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: a 6-month follow-up analysisComparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan.Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis.Barriers and facilitators of a healthy lifestyle among persons with serious and persistent mental illness: perspectives of community mental health providersClinical psychopharmacology of eating disorders: a research update.Reliability and practicality of measuring waist circumference to monitor cardiovascular risk among community mental health center patients.Off-label use of second generation antipsychotics for post-traumatic stress disorder in the Department of Veterans Affairs: time trends and sociodemographic, comorbidity, and regional correlates.Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics.
P2860
Q24202427-81360387-8559-4BB0-8AAB-3092483663C7Q24203649-46E04831-FB08-4618-AA26-2ACECD6C04EFQ24240260-423C5786-E8FB-4570-B8C5-945B09B9FCD2Q26849474-30D0DD5D-8CD5-44EB-9836-3DAFFB6D3433Q33718231-640BE03F-1F01-422D-8F1F-C696A473C5DCQ33865512-FB721FD8-7FCE-46E5-84FC-1CBE506AE411Q33940250-C960F6D4-DF4B-4C97-9FD0-E604AE227136Q34179974-46050CE5-0562-4DED-9707-0EB63E210FACQ34660592-7B9B7B21-0588-443D-9D5C-2A4195A3FCFDQ36087161-2AFEE629-4D29-43F8-8CBB-B4685CF71045Q36388181-156DDAB5-CC6E-40C4-BF00-A6F4D049DF84Q36631551-06D1DF49-BB7F-4C8A-9B7E-6128831ACB73Q37435547-ECEF6841-D3ED-4986-83BA-CB3A3637CAE9Q37621945-4600498A-0490-4D61-89EF-696AAA9A8275Q37635208-4C90B3F6-2E1E-485F-BE48-5D6E564BC561Q37707188-251A5E82-A75A-4F4F-9CC1-BEB2491E77D7Q37857919-254E8A79-E11D-4C90-9D8F-8333F3376D62Q40085053-0F9DDBC3-BD00-4FA4-BDDA-352D8CBEF5A7Q43413416-3AE5C30B-8240-42CC-8ECA-40F6F6EE2EBCQ48179219-4AA409D7-AF43-49D6-AF3F-F9F75EBEE35E
P2860
The impact of obesity on health care costs among persons with schizophrenia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The impact of obesity on health care costs among persons with schizophrenia
@en
The impact of obesity on health care costs among persons with schizophrenia.
@nl
type
label
The impact of obesity on health care costs among persons with schizophrenia
@en
The impact of obesity on health care costs among persons with schizophrenia.
@nl
prefLabel
The impact of obesity on health care costs among persons with schizophrenia
@en
The impact of obesity on health care costs among persons with schizophrenia.
@nl
P2093
P2860
P1476
The impact of obesity on health care costs among persons with schizophrenia
@en
P2093
Joseph P McEvoy
Lydia A Chwastiak
Marvin S Swartz
Sonia M Davis
T Scott Stroup
P2860
P356
10.1016/J.GENHOSPPSYCH.2008.09.012
P577
2008-10-23T00:00:00Z